(NYSE:GXO), Newly created role responsible for driving global operational excellence GREENWICH, Conn., Dec. 12, 2025 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world's largest pure-play contract logistics provider, today announced the appointment of Bart Beeks in the newly created role of Chief Operating Officer (COO), effective January 2, 2026. Beeks will lead GXO's […]
(Other OTC:OTCM),(OTC US:OTCM),(LSE:PBEE.L),(Other OTC:PBNYF), NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced PensionBee Group plc (LON: PBEE; OTCQX:PBNYF), a leading online retirement savings provider, has qualified to trade on the OTCQX(R) Best Market. PensionBee Group plc
(TSX-V:NLH),(OTC US:NVLPF),(Other OTC:NVLPF), NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 12, 2025 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, announces that the Company has issued stock options. The Company has granted
(NasdaqGM:RLAY), Efficacy data remain consistent with previous disclosures, showing 10.3-month median PFS in all patients and 11.4-month median PFS in 2L patients Subset analyses show broad activity in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer, regardless of prior fulvestrant or other SERD exposure, or ESR1 mutation status Phase 3 ReDiscover-2 trial in CDK4/6-experienced breast cancer
(NasdaqGM:CSTL), FRIENDSWOOD, Texas, Dec. 12, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a new systematic review and meta-analysis (SRMA) demonstrating that the TissueCypher(R) Barrett's Esophagus test provides clinically validated risk stratification for patients with Barrett's esophagus (BE).
(NASDAQ:BYSI), Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage position Plinabulin as a late-stage candidate showing survival improvement in 2L/3L EGFR WT NSCLC. FLORHAM PARK, N.J., Dec. 12, 2025 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI), a clinical-stage biopharmaceutical company developing first-in-class immune-modulating
Miami, Florida, Dec. 12, 2025 (GLOBE NEWSWIRE) — Harold Health announced the official release of the Harold Health app, a dedicated telehealth platform designed exclusively for men and built to support both mental and physical well-being. The app offers secure video and audio visits, messaging access, and fully encrypted health records while delivering prescriptions and
WINNIPEG, Manitoba, Dec. 12, 2025 (GLOBE NEWSWIRE) — MADD Canada is showcasing its 2025-2026 School Program in Winnipeg with Provincial Sponsor Manitoba Public Insurance (MPI). Today, a special screening will be held at Westwood Collegiate in Winnipeg, delivering life-saving messages to students about the dangers and consequences of impaired driving, an entirely preventable crime. Road
(NASDAQ:OPCH), BANNOCKBURN, Ill., Dec. 12, 2025 (GLOBE NEWSWIRE) — Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the 44th Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Tuesday, January 13, 2026, including a presentation at 10:30am
(SWX:NOVN),(LSE:68CT), FDA Commissioner Marty Makary, North Carolina Governor Josh Stein and Novartis leadership highlight importance of new hub to US patients and local economy Construction reflects company's commitment to ensure end-to-end manufacturing of all key medicines for US patients in the US at scale Groundbreaking marks continuation of Novartis investment and growth in the US,